Vyome Holdings (HIND) Gains from Investment Securities (2015 - 2025)
Vyome Holdings (HIND) posted quarterly Gains from Investment Securities of -$1000.0 for Q2 2025, down 150.0% year-over-year from $2000.0 in Q2 2024, and up 99.97% quarter-over-quarter from -$3.7 million in Q1 2025.
Vyome Holdings (HIND) Gains from Investment Securities (2015 - 2025) Analysis & Trends
Vyome Holdings' Gains from Investment Securities history runs 5 years deep, the most recent figure standing at -$1000.0 for Q2 2025.
- In Q2 2025, Gains from Investment Securities fell 150.0% year-over-year to -$1000.0; the TTM figure through Jun 2025 stood at -$3.7 million (down 705.01% YoY), while the FY2024 annual figure was -$52000.0, up 98.66% from the prior year.
- Gains from Investment Securities for Q2 2025 stood at -$1000.0, up from -$3.7 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $2000.0 in Q2 2024, with the low at -$3.7 million in Q1 2025.
- The 3-year median for Gains from Investment Securities is -$27500.0 (2023), against an average of -$759100.0.
- The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities jumped 100.42% in 2024, then tumbled 17333.33% in 2025.
- Vyome Holdings' Gains from Investment Securities stood at -$28000.0 in 2023, then soared by 78.57% to -$6000.0 in 2024, then surged by 83.33% to -$1000.0 in 2025.
- Business Quant data shows HIND's Gains from Investment Securities at -$1000.0 in Q2 2025, -$3.7 million in Q1 2025, and -$6000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -3.66 Mn |
| Mar 31, 2025 | -3.66 Mn |
| Dec 31, 2024 | -6,000.00 |
| Dec 31, 2024 | -6,000.00 |
| Sep 30, 2024 | -27,000.00 |
| Sep 30, 2024 | -27,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Dec 31, 2023 | -28,000.00 |
| Dec 31, 2023 | -28,000.00 |
| Sep 30, 2023 | -412,000.00 |
| Sep 30, 2023 | -412,000.00 |
| Jun 30, 2023 | -472,000.00 |
| Jun 30, 2023 | -472,000.00 |
| Mar 31, 2023 | -2.97 Mn |
| Mar 31, 2023 | -2.97 Mn |